Literature DB >> 30200724

[Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota].

Ting-Ting Sang1, Cheng-Jie Guo1, Dan-Dan Guo1, Xing-Ya Wang1.   

Abstract

Traditional Chinese medicine(TCM) has been increasingly used in the prevention and treatment of obesity and obesity-related diseases. However, its mechanism of action is not yet clear. In recent years, with the development of high-throughput sequencing technology, scientific researches have found that the disorder of gut microbiota is associated with obesity and other diseases. Furthermore, it has been found that TCM can improve the structure of gut microbiota by increasing probiotics and reducing pathogens, which play an importent role in preventing the development and progression of obesity and other diseases. This article first explores the possible association between intestinal microbiota and obesity. Then, it reviews the traditional Chinese medicine and its role in regulating intestinal microbiota for the prevention and treatment of diseases, including obesity and inflammation, insulin resistance, type 2 diabetes, non-alcoholic fatty liver disease, inflammatory bowel disease and other diseases, in theexpectation of new strategies and research direction for treating obesity and relevant diseases, and providing important guidance for further studies in this field in the future. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  inflammatory bowel disease ; insulin resistance ; intestinal microbiota ; non-alcoholic fatty liver disease ; obesity ; traditional Chinese medicine ; type 2 diabetes

Mesh:

Year:  2018        PMID: 30200724     DOI: 10.19540/j.cnki.cjcmm.20180423.003

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Zhang Zhen; Lin Xia; Huang You; Zhou Jingwei; Yang Shasha; Wei Xinyi; Lai Wenjing; Zhang Xin; Fu Chaomei
Journal:  Front Pharmacol       Date:  2021-11-30       Impact factor: 5.810

Review 2.  Cross-Talk between Gut Microbiota and the Heart: A New Target for the Herbal Medicine Treatment of Heart Failure?

Authors:  Lin Li; Senjie Zhong; Bin Cheng; Hong Qiu; Zhixi Hu
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-06       Impact factor: 2.629

3.  Icariin Inhibits Intestinal Inflammation of DSS-Induced Colitis Mice Through Modulating Intestinal Flora Abundance and Modulating p-p65/p65 Molecule.

Authors:  Haoran Zhang; Shixuan Zhuo; Danni Song; Leyao Wang; Junyi Gu; Junyan Ma; Yang Gu; Minghui Ji; Meijuan Chen; Yuanyuan Guo
Journal:  Turk J Gastroenterol       Date:  2021-04       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.